Collectively, we proposed that within the tumor microenvironment, some early activated TNBC cells will interact with macrophages to elevate the levels of ROS, which activate the ERK1/2‐c‐Jun and NF‐κB signaling pathways to increase the expression of IL1α. The gene discussed is MAPK3; the disease is neoplasm.